Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxycillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxycillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxycillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amoxycillin trihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections (acute and chronic): h, influenzae; streptococcus; s. pneumoniae; staphylococcus, non-pencillinase producing; e. coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic): e, coli (see microbiology); p. mirabilis; s. faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staphylococcus, non-penicillinase producing; streptococcus; e. coli (see microbiology). prophylaxis of endocarditis. amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathogens with established penicillin g susceptibility should preferentially be treated with penicillin g.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - amoxicillin trihydrate (equivalent: amoxicillin, qty mg) - capsule, hard - excipient ingredients: magnesium stearate; microcrystalline cellulose; iron oxide yellow; titanium dioxide; gelatin - treatment of the following infections due to susceptible strains of sensitive organisms: note: therapy should be guided by bacteriologic studies including sensitivity tests and by clinical response. amoxycillin, alone or in combination with another antibiotic, may be used in an emergency where the causative agent has yet to be identified. respiratory tract infections: (acute and chronic): h.influenzae; streptococcus; s.pneumoniae; staphylococcus, non-penicillinase producing; e.coli (see microbiology). urogenital infections (complicated and uncomplicated, acute and chronic) e.coli (see microbiology); p.mirabilis; s.faecalis. gonorrhoea (n.gonorrhoeae, non-penicillinase producing). skin and skin structure infections: staaphylococcus, non-penicillinase producing: streptococcus: e.coli (see microbiology). prophylaxis of endocarditis: amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis. infections caused by pathgogens with established pencicillin g susceptibility should be preferentially treated with penicillin g.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

norbrook laboratories australia pty limited - amoxycillin as amoxycillin trihydrate - parenteral liquid/solution/suspension - amoxycillin as amoxycillin trihydrate antibiotic active 150.0 mg/ml - antibiotic & related - cat | cattle | dog | horse | pigs | sheep | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | - actinobacillus equuli | actinobacillus lignieresii | actinomyces bovis | bacillus anthracis | bordetella bronchiseptica | clostridium spp. | corynebacterium spp. | erysipelothrix rhusiopathiae | fusiformis spp. | haemophilus spp. | moraxella spp. | pasteurella spp. | proteus mirabilis | staphylococci | streptococci | anthrax | bacterial canker | canine cough syndrome | clostridium botulinum | clostridium chauvoei | clostridium fallax | clostridium feseri | clostridium hemolyticum | clostridium novyi | clostridium perfringens types | clostridium septicum | clostridium sordelli | clostridium sporogenes | clostridium tetani | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | infectious tracheobronchitis | pasterellosis | pasteurellosis

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram limited - amoxycillin trihydrate - capsules - each capsule contains amoxycillin trihydrate equiv. to amoxycillin 250 mg

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram limited - amoxycillin trihydrate - dry powder - each 5 ml suspension contains amoxycillin trihydrate equiv. to amoxycillin 125 mg

Namibia - English - Namibia Medicines Regulatory Council

adcock ingram limited - amoxycillin trihydrate - dry powder - each 5 ml suspension contains amoxycillin trihydrate equiv. to amoxycillin 250 mg